A new interview with our President, Jun Katsura has been published by Nikkei BioTech Online. 9月 4, 2026
LinDo K.K., Signs Licensing Agreement with Proveca Ltd. to Develop and Commercialize Sialanar® in Japan for the treatment of Sialorrhea in Paediatric Patients with Chronic Neurological Disorders ~ Addressing the Challenge of ‘Drug Loss’ and Ensuring Access to Innovative Medicines in Japan ~ 7月 15, 2026
